Navigation Links
Generex and RXi Pharmaceuticals Announce Positive Research Data Using RNAi Technology in the Development of Therapeutic Vaccines for Cancer
Date:1/6/2011

oimmune diseases.  Antigen Express has pioneered the use of specific CD4+ T helper stimulation in immunotherapy.  One of its platform technologies relies on inhibition of expression of the Ii protein.  Antigen Express scientists, and others, have shown clearly that suppression of expression of the Ii protein in cancer cells allows for potent stimulation of T helper cells and prevents the further growth of cancer cells.  For more information, visit the Generex website at www.generex.com or the Antigen Express website at www.antigenexpress.com.

About RXi Pharmaceuticals Corporation

RXi Pharmaceuticals Corporation is a recognized leader in RNAi-based therapeutic discovery and development with a comprehensive therapeutic platform that includes both RNA interference (RNAi) compounds and delivery methods.  RXi's sd-rxRNA compounds were developed by our team of world-class scientists, are designed specifically for therapeutic use, and contain many of the properties that are needed to advance RNAi based drugs into the clinic (high potency, reduced immune response activation, novel intellectual property, etc).  The Company is leveraging this broad and integrated RNAi therapeutic platform to build a pipeline of RNAi therapeutics for the treatment of a number of disease areas, including its core focus of developing treatments for dermal anti-scarring and retinal disorders as well as a continued interest in oncology and indications accessible by spinal cord delivery.  RXi Pharmaceuticals believes it is well positioned to compete successfully in the RNAi therapeutics market based on the strength of its next generation therapeutic platform, experienced management team, accomplished Scientific Advisory Board, including Nobel Laureate, Dr. Craig Mello, and its broad intellectual property position in RNAi chemistry and delivery.  

SOURCE Generex Biotechnology Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Generex Biotechnology Corporation Initiation Coverage Review Issued By Scimitar Equity, LLC
2. Generex Announces Distribution Agreement for Generex Oral-lyn™ in Chile
3. Generex Announces Presentations of Novel Vaccine Strategies
4. Generex Announces Approval of Adjournment Proposal and Adjourned Special Meeting Date
5. Generex Announces Sales Agreement with Elias Shaker & Company
6. Generex Presents Abstract at EASD Annual Meeting
7. Generex Awarded a New Patent in Canada for its Proprietary Buccal Drug Delivery System
8. Generex Biotechnology Provides a Corporate Update to Address Managements Strategic Initiatives for Growth
9. Generex Reaches Agreement to Acquire 51% Stake in Global Medical Direct, a Nationwide Durable Medical Equipment and Pharmaceutical Provider Specializing in Direct-to-Consumer Diabetes Supplies
10. Generex Provides Clarification for Special Meeting Voting
11. Generex Announces That Adjournment Will be Sole Matter Considered at Reconvened Special Meeting of Stockholders on October 15, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... , July 2, 2015 Leading ... to capture critical product and market insights in ... benefits to employee-based studies, it is essential for ... own internal employees to capture critical business-related insights. ... benchmarking firm, Best Practices, LLC, most benchmarked companies ...
(Date:7/2/2015)... , July 2, 2015  Before you head outdoors ... so you can stay safe and healthy. Take steps to ... Infographic http://nyackhospital.org/summersafety Protect Your Skin From ... the sun can increase your risk of skin cancer. To ... as much as possible, especially during midday hours. Wear a ...
(Date:7/2/2015)... 2015 Research and Markets( http://www.researchandmarkets.com/research/nlfg34/cancer ) ... Technology, Imaging and by Application - Forecast to 2020" report ... expected to reach $13.1 Billion in 2020 from an estimated $7.1 ... The market is dominated by North America , ... , and Rest of the World (RoW). The cancer diagnostics market ...
Breaking Medicine Technology:Leveraging Employee Insights to Produce Cutting-Edge Market Research 2First Aid Summer Survival Tips from Nyack Hospital 2First Aid Summer Survival Tips from Nyack Hospital 3Global Cancer Diagnostics Market Report 2015 - Technology, Imaging and by Applications Forecasts to 2020 for the $13 Billion Industry 2
... Healthcare Systems is pleased to announce that its InsightCS® ... at University Behavioral HealthCare (UBHC) with more than 800 ... Jersey. UBHC, a division of the University ... utilizing the InsightCS® system,s complete, end-to-end Patient Access (Registration, ...
... CITY, N.J., Dec. 7, 2011 Aoxing Pharmaceutical ... a specialty pharmaceutical company focusing on research, development, ... treatment pharmaceuticals, today announced that its operating subsidiary ... signed a three-way financing agreement with Shijiazhuang Construction ...
Cached Medicine Technology:University Behavioral HealthCare Goes Live with Stockell Healthcare Systems' InsightCS® Revenue Cycle Information Management System 2Aoxing Pharmaceutical Company Announces $3.2 Million Financing 2Aoxing Pharmaceutical Company Announces $3.2 Million Financing 3
(Date:7/4/2015)... ... 2015 , ... Tyler Boden, Project Developer of Sullivan Solar ... the North American Board of Certified Energy Practitioners (NABCEP®), and is now a ... well established national certification organization for renewable energy professionals. Designation as a NABCEP ...
(Date:7/3/2015)... ... July 03, 2015 , ... Scientists at several top US ... with even minimal asbestos exposure. Click here to read the complete story , ... Hawaii Cancer Center, Cedars Sinai Medical Center, and New York University exposed mice with ...
(Date:7/3/2015)... ... ... Smoothies are all the rage right now and all you need to ... Natural is proud to introduce a new line of all natural products that blend ... minerals! , Aurora is offering a variety of blends and stand-alone items to choose ...
(Date:7/3/2015)... ... July 03, 2015 , ... Yisrayl Hawkins, Pastor and Overseer at The ... he says will reveal biblical truth and expose popular lies regarding proper relationships according ... Don’t Have Sex”, immediately goes into the core of the subject by explaining why ...
(Date:7/2/2015)... , ... July 02, 2015 , ... sweetFrog Enterprises, LLC. ... opening is now the 19th sweetFrog store located in the Lone Star State. The ... fastest growing companies in 2014. , The store, which opened July 1 at Duke’s ...
Breaking Medicine News(10 mins):Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 2Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 3Health News:Study Finds Small Amounts of Asbestos May Trigger Mesothelioma in People with Genetic Mutation, According to Surviving Mesothelioma 2Health News:Aurora Product, Inc. Announces An Original New Line: Smoothie Fixins’ 2Health News:Yisrayl Hawkins Explains What the Bible Really Says about Sex in New Publication This Week 2Health News:sweetFrog Expands Texas Footprint with Location in Canton 2
... side effect when combined with a type of medication ... of the saquinavir, one of a class of ... the progression of HIV infection. In the presence of ... 50 percent. ,For the study, nine healthy, HIV-negative ...
... treat everything from heartburn to impotence have prompted one in ... to retain critical information about the drug and possible side ... the Food and Drug Administration set up rules and made ... ads have a considerable effect -- nearly a third of ...
... Novartis' Femara (letrozole), one of a new class of ... tamoxifen in treating breast cancer in women// with advanced ... of drugs called aromatase inhibitors, which work differently to ... ,This new drug, Letrozole shrank tumors better and ...
... of old ladies are the latest mood-enhancing substances to ... those of young men may have the reverse effect. ... due to the human ability to detect the presence ... reports "New Scientist" magazine. ,Denise Chen, at ...
... A new method of treating childhood brain tumours, aimed at ... be trialled at hospitals around the US. Researchers will enrol ... childhood brain tumour – who will be treated with lower ... ,In the US, about 500 children are diagnosed ...
... long-delayed move, the Foods and Drugs Department is beginning ... without qualified pharmacists, an offence under the Indian Drugs ... sources, not only does this common practice jeopardise the ... to deal with high-risk drugs -- it also endangers ...
Cached Medicine News:
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: